» Articles » PMID: 6326131

Monoclonal Integration of Human T-cell Leukemia Provirus in All Primary Tumors of Adult T-cell Leukemia Suggests Causative Role of Human T-cell Leukemia Virus in the Disease

Overview
Specialty Science
Date 1984 Apr 1
PMID 6326131
Citations 264
Authors
Affiliations
Soon will be listed here.
Abstract

The genome of human T-cell leukemia virus (HTLV) was surveyed in fresh tumor cells of 163 patients with lymphoma and leukemia from the southwest part of Japan where adult T-cell leukemia (ATL) is endemic. Leukemic cells of all 88 cases of ATL tested so far were found to contain the provirus genome and also found to be monoclonal with respect to the integration site of provirus genome. In most cases of ATL, leukemic cells contained one or two copies of the complete HTLV provirus genome, and it was shown that the single species of HTLV with a fully determined sequence is typical in ATL. Some cases of T-cell malignancies, diagnosed as chronic lymphocytic leukemia or non-Hodgkin lymphoma, also had the provirus genome in their tumor cells, whereas some cases with the same diagnosis did not. No cases of other types of lymphoma or leukemia contained the provirus genome in their tumor cells. Monoclonal integration of the HTLV provirus genome in all primary tumor cells of ATL not only indicates that HTLV directly interacts with target cells, which become leukemic, and that integration of the provirus genome is a prerequisite for development of ATL and possibly other related diseases but also indicates that the virus is not associated with other types of lymphoma or leukemia.

Citing Articles

Virus-host immune interaction in asymptomatic HTLV-1 carriers.

Asigbee T, Nakamura-Hoshi M, Kuse N, Ishii H, Ishikawa K, Kawana-Tachikawa A Microbiol Spectr. 2025; 13(3):e0250724.

PMID: 39887247 PMC: 11878079. DOI: 10.1128/spectrum.02507-24.


Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis.

Arone C, Dutartre H, Muriaux D Bio Protoc. 2024; 14(24):e5152.

PMID: 39735296 PMC: 11669908. DOI: 10.21769/BioProtoc.5152.


Current State of Therapeutics for HTLV-1.

Wang T, Hirons A, Doerflinger M, Morris K, Ledger S, Purcell D Viruses. 2024; 16(10).

PMID: 39459949 PMC: 11512412. DOI: 10.3390/v16101616.


HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.

Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E Int J Mol Sci. 2024; 25(13).

PMID: 38999966 PMC: 11241684. DOI: 10.3390/ijms25136858.


Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity.

Egawa Y, Higuchi T, Hashida Y, Ueno K, Kojima K, Daibata M Sci Rep. 2024; 14(1):12549.

PMID: 38822041 PMC: 11143202. DOI: 10.1038/s41598-024-63494-x.


References
1.
Yoshida M . Human leukemia virus associated with adult T-cell leukemia. Gan. 1983; 74(6):777-89. View

2.
Schupbach J, Kalyanaraman V, Sarngadharan M, Blattner W, Gallo R . Antibodies against three purified proteins of the human type C retrovirus, human T-cell leukemia-lymphoma virus, in adult T-cell leukemia-lymphoma patients and healthy Blacks from the Caribbean. Cancer Res. 1983; 43(2):886-91. View

3.
Payne G, Courtneidge S, Crittenden L, Fadly A, Bishop J, Varmus H . Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell. 1981; 23(2):311-22. DOI: 10.1016/0092-8674(81)90127-6. View

4.
Neel B, Hayward W, Robinson H, Fang J, Astrin S . Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell. 1981; 23(2):323-34. DOI: 10.1016/0092-8674(81)90128-8. View

5.
Hayward W, Neel B, Astrin S . Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature. 1981; 290(5806):475-80. DOI: 10.1038/290475a0. View